BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3864905)

  • 1. Malignant bone and soft-tissue tumor and HLA.
    Wong AC
    Nihon Seikeigeka Gakkai Zasshi; 1985 Jul; 59(7):719-33. PubMed ID: 3864905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA phenotype in patients with osteosarcoma].
    Shimizu T
    Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):269-73. PubMed ID: 2738427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR and MT associations with the clinical and serologic manifestations of pauciarticular onset juvenile rheumatoid arthritis.
    Sher MR; Schultz JS; Ragsdale CG; Kapur JJ; Sullivan DB; Cassidy JT
    J Rheumatol; 1985 Feb; 12(1):114-8. PubMed ID: 3872364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
    Darke C; Wagner MM; Nuki G; Dyer PA
    Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR antigens in juvenile chronic arthritis.
    Balogh Z; Gyodi E; Petranyi G; Meretey K; Bozsoky S
    J Rheumatol; 1982; 9(3):448-50. PubMed ID: 6956735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-D antigens in a Czech population and their association with HLA-DR antigens.
    Hinzová E; Ivasková E; Cukrová V; Rychlíková M
    Folia Biol (Praha); 1980; 26(4):267-74. PubMed ID: 6773825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA phenotypes in patients who have osteosarcoma.
    Shimizu T; Chigira M; Nagase M; Watanabe H; Udagawa E
    J Bone Joint Surg Am; 1990 Jan; 72(1):68-70. PubMed ID: 2295675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved definition of human leukocyte antigen frequencies among minorities and applicability to estimates of transplant compatibility.
    Leffell MS; Cherikh WS; Land G; Zachary AA
    Transplantation; 2007 Apr; 83(7):964-72. PubMed ID: 17460569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 12. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of unidentified HLA antigens in pulmonary tuberculosis.
    Teran L; Selman M; Mendoza M; Rubio H; Bañales JL; Granados J
    Ann Clin Res; 1985; 17(1):40-2. PubMed ID: 3860182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behçet's disease and HLA antigens--an association with a new specificity recognized by a monoclonal antibody].
    Nakayama T
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):643-52. PubMed ID: 2416665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR (Ia-like) reactivity in tumors of bone and soft tissue: an immunohistochemical comparison of monoclonal antibodies LN3 and LK8D3 in routinely processed specimens.
    Swanson PE; Wick MR
    Mod Pathol; 1990 Mar; 3(2):113-9. PubMed ID: 1691491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histocompatibility profile of selected Latin American countries.
    Santiago-Delpín EA
    Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA class II antigen associations help to define two types of alopecia areata.
    Colombe BW; Price VH; Khoury EL; Garovoy MR; Lou CD
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):757-64. PubMed ID: 7593774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens and spinal muscular atrophy.
    Dick DJ; Dewar PJ; Gardner-Medwin D
    J Neurogenet; 1984 Sep; 1(3):219-23. PubMed ID: 6598804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.